Intangible assets—The carrying amounts, accumulated amortization, net carrying value, and weighted average remaining life of our definite-lived amortizable intangible assets are presented below (dollars in thousands, useful life in years):


	March 31, 2026						June 30, 2025
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount			Gross Carrying Amount		Impairment Charges		Accumulated Amortization		Net Carrying Amount
Customer relationships	$	1,423	$	(1,404)	$	19		$	17,492	$	(4,209)	$	(13,252)	$	31
Trade name	—		—		—			2,680		—		(2,680)		—
Proprietary software	4,342		(3,243)		1,099			4,342		—		(2,418)		1,924
Non-compete agreements	100		(98)		2			100		—		(82)		18

Total intangible assets	$	5,865	$	(4,745)	$	1,120		$	24,614	$	(4,209)	$	(18,432)	$	1,973

The Company's intangible assets include those long-lived intangible assets acquired as part of acquisitions. The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. There were no impairment triggers identified with respect to the Company’s long-lived assets during the three and nine months ended March 31, 2026 and 2025.

For the three months ended March 31, 2026 and 2025, amortization expense related to intangible assets totaled $0.3 million and $1.0 million, respectively, and $0.9 million and $3.1 million for the nine months ended March 31, 2026 and 2025, respectively, recorded in selling, general and administrative expense in the condensed consolidated statements of comprehensive income. The weighted-average remaining useful life of intangible assets was 1.0 years and 1.8 years as of March 31, 2026 and June 30, 2025, respectively.


	Proprietary Software		Non-compete agreements		Customer relationships		Total

Remainder of 2026	$	275	$	2	$	5	$	282
2027	824		—		14		838



Total	$	1,099	$	2	$	19	$	1,120

Goodwill—The Company recorded as goodwill the excess of the purchase price over the estimated fair values of identifiable assets and liabilities acquired as part of prior period acquisitions. Goodwill is assigned to reporting units that are expected to benefit from the synergies of the business combination as of the acquisition date and becomes identified with that reporting unit in its entirety. As such, the reporting unit as a whole supports the recovery of its goodwill. As of March 31, 2026, the Company’s goodwill balance of $29.4 million, all of which is assigned to the Healthcare Services reporting unit and reportable segment, was related to the acquisitions of Express Meds, Simple Meds, and SelectPatient Management.

The Company performs its annual goodwill impairment testing as of April 1, or more frequently if it believes that indicators of impairment exist. During the three and nine months ended March 31, 2026 and 2025, there were no indicators of impairment.